SCHEMBL3068504

SCHEMBL3068504

C[C@@H](c1ccccc1)N(C(=O)c1ccccc1C(=O)O)[C@@H](C)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.50
ALOX15 P16050 2/20 0.50
ALDH1A1 P00352 2/20 0.50
ALOX5 P09917 1/20 0.47
KDM4E B2RXH2 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
NR1I2 O75469 1/20 0.45
MYC P01106 3/20 0.43
NR4A1 P22736 1/20 0.43
MTOR P42345 1/20 0.42
MAPT P10636 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
AKR1C3 P42330 1/20 0.41
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL604822 1.00 TRPM8 (0.50) TRPM8ALOX15ALDH1A1ALOX5KDM4E
SCHEMBL3062350 1.00 TRPM8 (0.50) TRPM8ALOX15ALDH1A1ALOX5KDM4E
SCHEMBL6457702 0.86 TRPM8 (0.55) TRPM8ALDH1A1ALOX5KDM4ENR1I2
SCHEMBL5805578 0.84 ALOX5 (0.59) TRPM8ALOX15ALDH1A1ALOX5MYC
SCHEMBL21891698 0.83 ALDH1A1 (0.56) ALOX15ALDH1A1KDM4EMYCNR4A1
SCHEMBL28566234 0.79 ALOX5 (0.47) TRPM8ALOX15ALDH1A1ALOX5KDM4E
SCHEMBL29980356 0.79 ALOX5 (0.47) TRPM8ALOX15ALDH1A1ALOX5KDM4E
SCHEMBL28549723 0.79 ALOX5 (0.47) TRPM8ALOX15ALDH1A1ALOX5KDM4E
Phthalic Acid SCHEMBL28418540 0.76 ALDH1A1 (0.78) ALOX15ALDH1A1KDM4EMYCNR4A1
Phthalic Acid SCHEMBL28043206 0.75 ALDH1A1 (0.61) ALOX15ALDH1A1KDM4ETAAR1MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230122169-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE CELLTRION, INC. (KR) 2023-04-20 US claimed
EP-3858816-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE Celltrion, Inc. (KR) 2021-08-04 EP claimed
WO-2020067683-A1 NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE CELLTRION INC. (KR) 2020-04-02 WO claimed
US-12533343-B2 Method for preparing (−)-cibenzoline succinate CELLTRION, INC. (KR) 2026-01-27 US disclosed
US-20250135005-A1 PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES TAMBO INC (US) 2025-05-01 US disclosed
US-12194100-B2 Processes for preparing functionalized cyclooctenes TAMBO, INC. (US) 2025-01-14 US disclosed
US-20230122169-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE CELLTRION, INC. (KR) 2023-04-20 US disclosed
US-20210346502-A1 PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES TAMBO INC (US) 2021-11-11 US disclosed
EP-3858816-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE Celltrion, Inc. (KR) 2021-08-04 EP disclosed
CN-112739686-A Novel process for the preparation of (-) -xylometazoline succinate 赛特瑞恩股份有限公司 2021-04-30 CN disclosed
WO-2020067683-A1 NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE CELLTRION INC. (KR) 2020-04-02 WO disclosed
US-20100222257-A1 SUBSTITUTED PHENETHYLAMINES AUSPEX PHARMACEUTICALS, INC. (US) 2010-09-02 US disclosed
US-7745665-B2 Substituted phenethylamines AUSPEX PHARMACEUTICALS, INC. (US) 2010-06-29 US disclosed
US-20090203763-A1 SUBSTITUTED BENZHYDRYLETHERS AUSPEX PHARMACEUTICALS, INC. (US) 2009-08-13 US disclosed
US-20080300316-A1 isotopically enriched phenylephrine derivatives, used for the treatment and/or management of nasal congestion, headaches, asthma, chronic obstructive pulmonary diseases, ischemia, hypotension, and/or any disorder ameliorated by modulating alpha-adrenergic receptors AUSPEX PHARMACEUTICALS, INC. (US) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300316-A1 isotopically enriched phenylephrine derivatives, used for the treatment and/or management of nasal congestion, headaches, asthma, chronic obstructive pulmonary diseases, ischemia, hypotension, and/or any disorder ameliorated by modulating alpha-adrenergic receptors ADRB1, ADRB2, ADRA1A TRPM8 565/4885ALOX15 1067/4885ALDH1A1 1022/4885
US-12194100-B2 Processes for preparing functionalized cyclooctenes PPOX, SCO2, CYCS TRPM8 4491/4885ALOX15 113/4885ALDH1A1 4078/4885
US-20090203763-A1 SUBSTITUTED BENZHYDRYLETHERS UGT2B7, CYP3A7, CYP3A43 TRPM8 4169/4885ALOX15 3267/4885ALDH1A1 103/4885
US-20230122169-A1 NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE SDHA, SDHB, ALDH5A1 TRPM8 4023/4885ALOX15 3667/4885ALDH1A1 230/4885
US-20210346502-A1 PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES PPOX, SCO2, CYCS TRPM8 4491/4885ALOX15 113/4885ALDH1A1 4078/4885
US-20250135005-A1 PROCESSES FOR PREPARING FUNCTIONALIZED CYCLOOCTENES PPOX, SCO2, CYCS TRPM8 4491/4885ALOX15 113/4885ALDH1A1 4078/4885
US-20100222257-A1 SUBSTITUTED PHENETHYLAMINES ADRB1, ADRA2C, ADRB2 TRPM8 921/4885ALOX15 3679/4885ALDH1A1 489/4885
US-12533343-B2 Method for preparing (−)-cibenzoline succinate CIP2A, CACNA1A, SDHA TRPM8 3722/4885ALOX15 4487/4885ALDH1A1 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.